Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.
We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
At Daiichi Sankyo, we believe progress depends on asking more of science.
We are 20,000 people across 30 countries, united by the courage to challenge assumptions and pursue better answers. Across oncology and beyond, we develop new medicines and new approaches to discovery and delivery, addressing unmet medical needs and bringing treatment options within reach.
Since 1899, curiosity, rigor and perseverance have shaped how we work. Behind every treatment is a person, a family and a future. That human purpose drives us to keep learning, questioning and advancing science for patients around the world.
For more information, please visit www.daiichisankyo.com
See our community guidelines here: https://www.daiichisankyo.com/community_guidelines/index.html